Table 2.
Unadjusted β (SE) |
Model a β (SE) |
Model 2b β (SE) |
Model 2ac β (SE) |
Model 2bd β (SE) |
Model 2ce β (SE) |
Model 2df β (SE) |
|
---|---|---|---|---|---|---|---|
AGR | |||||||
HSV | 0.023 (0.010) * | 0.018 (0.008) * | 0.019 (0.008) * | 0.016 (0.008) * | 0.016 (0.008) * | 0.015 (0.008) | 0.018 (0.008) * |
HSD | −0.017 (0.008) * | −0.003 (0.006) | −0.003 (0.006) | −0.004 (0.006) | −0.004 (0.006) | −0.004 (0.006) | −0.003 (0.008) |
AWP | |||||||
HSV | 0.34 (0.14) * | 0.21 (0.11) * | 0.21 (0.11) * | 0.19 (0.11) | 0.20 (0.11) * | 0.19 (0. 11) | 0.21 (0.11) * |
HSD | −0.15 (0.10) | −0.02 (0.08) | −0.01 (0.08) | −0.03 (0.08) | −0.02 (0.08) | −0.03 (0.08) | −0.02 (0.08) |
GWP | |||||||
HSV | −0.08 (0.23) | −0.31 (0.20) | −0.31 (0.20) | −0.25 (0.20) | −0.25 (0.20) | −0.25 (0.20) | −0.29 (0.20) |
HSD | 0.51 (0.16) ** | 0.18 (0.15) | 0.18 (0.15) | 0.20 (0.15) | 0.20 (0.15) | 0.20 (0.15) | 0.19 (0.15) |
VAT Area | |||||||
HSV | 10.17 (3.66) ** | 6.59 (2.82) * | 6.86 (2.82) * | 6.03 (2.86) * | 6.42 (2.85) * | 5.53 (2.88) | 6.69 (2.84) * |
HSD | −5.38 (2.71) * | −0.42 (2.12) | −0.46 (2.10) | −0.85 (2.11) | −0.66 (2.11) | −1.02 (2.10) | −0.59 (2.11) |
SAT Area | |||||||
HSV | 45.40 (14.73) ** | 25.60 (9.57) ** | 25.64 (9.58) ** | 23.91 (9.74) * | 24.08 (9.69) * | 22.22 (9.77) * | 25.68 (9.65) * |
HSD | −5.07 (10.99) | −3.91 (7.21) | −4.06 (7.14) | −4.88 (7.18) | −4.32 (7.17) | −5.51 (7.17) | −4.04 (7.19) |
TAT Area | |||||||
HSV | 55.57 (17.83) ** | 32.46 (12.07) ** | 32.50 (12.09) ** | 29.93 (12.28) * | 30.50 (12.22) * | 27.75 (12.31) * | 32.37 (12.16) ** |
HSD | −10.45 (13.29) | −4.33 (9.10) | −4.52 (9.00) | −5.73 (9.05) | −4.98 (9.05) | −6.53 (9.03) | −4.63 (9.06) |
AGR, android/gynoid fat mass ratio; AWP, android/whole body fat mass proportion; GWP, gynoid/whole body fat mass proportion; HSD, habitual sleep duration; HSV, habitual sleep variability; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue; TAT, total adipose tissue.
Model 1: Adjusted for age, race, sex, and body mass index percentile. HSV and HSD were entered into separate models.
Model 2: Adjusted for age, race, sex, and body mass index percentile. HSV and HSD were included the same model to adjust for each other.
Model 2a: Model 2 + additional adjustment of total caloric intake.
Model 2b: Model 2 + additional adjustment of total fat intake.
Model 2c: Model 2 + additional adjustment of carbohydrate intake.
Model 2d: Model 2 + additional adjustment of protein intake.
p < 0.05;
p < 0.01.